username: password:     Join free | Forgot password
Add to favorites    中文
home > news and events
AMSBIO:Comprehensive Tissue Biorepository and Collection Services

Clicks:578 Date:04/24/13
AMSBIO has announced further expansion of its tissue biorepository and collection services** to now include blood products from human donors with auto-immune and neurological conditions. Whole blood, plasma, serum, PBMCs and cerebrospinal fluid samples are available from a wide variety of donors.  In addition AMSBIO is now able to offer collection services of patient samples that meet the demographic and medical history requirements of specific research studies.

Drawing upon over 20 years of serving this market - AMSBIO has established one of the most comprehensive ranges of tissue products to advance personalised medicine by putting these valuable samples in the hands of leading researchers.

Samples are available isolated from hundreds of different source tissues including human normal and diseased tissues, and a variety of genetic model organisms including mouse, rat, primates and plant species. These specimens are provided ready-to-use enabling the immediate study of molecules of interest eliminating the need for time consuming in-house sample collection and preparation.

These tissue products further extend AMSBIO's extensive bank of clinical and veterinary specimens that form a unique range of specimens in formalin fixed paraffin embedded (FFPE) or snap frozen formats. This extensive library of samples includes genomic DNA preparations, tissue specific PCR-ready first strand cDNAs, universal cDNA and 96 well and 384 well cDNA panels. Total, universal RNA and micro and total protein lysates are also available.


All tissue products are produced using rigorous standard operating procedures and through ethical procurement to ensure only the highest quality materials. For further information on our tissue biorepository and  collection services please visit
http://www.amsbio.com/Tissues.aspx** or contact AMSBIO on +44-1235-828200 / +1-800-987-0985 or email info@amsbio.com.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and development in the medical, nutrition, cosmetics and energy industries. The AMSBIO range includes specialist antibodies, peptides and recombinant proteins. In addition the company is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as experts in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance screening outcomes and eventual prognosis. With a range of molecular detection reagents, and a significant Biorepository the company can also provide tissue DNA, RNA, protein and microarray products. Key research areas for these products include: Oncology, Regenerative Medicine, Environmental Analysis, Cytotoxicity Screening, Glycomics and Stem Cell Biology.

---------------------

Worldwide HQ

AMS Biotechnology (AMSBIO)
184 Milton Park
Abingdon
Oxon OX14 4SE
UK

Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com
Web www.amsbio.com
 
 
North American HQ
 
AMSBIO LLC
23591 El Toro Road, Suite#180
Lake Forest, CA 92630
USA
 
Tel: +1-800-987-0985
Email: info@amsbio.com
Related News>> more
  • Veolia Confirms Leading Edge With Contract At Largest Petrochemical Site In Taiwan4/8/2014
  • Crossing Continents: Mosaic Sample Management Software in Asia1/9/2014
  • INFORS HT Opens New Offices in the USA1/6/2014
  • Telstar Develops High Containment Barrier Systems Designed for API's Manufacturing and Research of...11/20/2013
  • Thermo Fisher Sponsored Yuxi Primary School to Participate in the 鈥淪ports for All鈥 Games11/6/2013
  • AB SCIEX Expands in Singapore to Drive Scientific Innovation10/31/2013
  • Seward Introduces Searchable Online Database for Sample Preparation Protocols10/30/2013
  • Illumina Signs Agreement to Acquire NextBio, Leader in Analyzing and Aggregating Complex Genomic D...10/29/2013
  • RephiLe participated 2013 international conference of environmental specimen bank10/21/2013
  • Sartorius Stedim Biotech and BD Strengthen Cooperation in the Area of Microbiological Diagnostics10/17/2013
  • advertisement

    Copyright(C) 2006-2014 bio-equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙